MarieCecile DVM - OmniAb Senior Genetics
OABIW Stock | USD 0.30 0.04 11.65% |
Executive
MarieCecile DVM is Senior Genetics of OmniAb Inc
Address | 5980 Horton Street, Emeryville, CA, United States, 94608 |
Phone | 510 250 7800 |
Web | https://www.omniab.com |
OmniAb Management Efficiency
The company has return on total asset (ROA) of (0.1376) % which means that it has lost $0.1376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2045) %, meaning that it generated substantial loss on money invested by shareholders. OmniAb's management efficiency ratios could be used to measure how well OmniAb manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.39 in 2024. Return On Capital Employed is likely to drop to -0.21 in 2024. At this time, OmniAb's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 2.9 M in 2024, whereas Other Assets are likely to drop slightly above 92 K in 2024.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Mark JD | PVH Corp | 62 | |
Sheryl Freeman | PVH Corp | N/A | |
Sara Bland | PVH Corp | N/A | |
Donald Kohler | PVH Corp | N/A | |
Lisa Powell | Citi Trends | 54 | |
David Savman | PVH Corp | N/A | |
Eunice Han | Skechers USA | N/A | |
Zachary Coughlin | PVH Corp | 49 | |
Ellen Constantinides | PVH Corp | N/A | |
Vivek Bhargava | Citi Trends | 52 | |
Katrina George | Citi Trends | N/A | |
Jessica Berkowitz | Citi Trends | 45 | |
Amba Subrahmanyam | PVH Corp | 50 | |
Gary Cribb | Ross Stores | 59 | |
MD MBA | Silo Pharma | 59 | |
Amber McCann | PVH Corp | N/A | |
Ester Jimenez | PVH Corp | N/A | |
James Fassio | Ross Stores | 69 | |
Eva Serrano | PVH Corp | 51 | |
Pete Calichman | Skechers USA | N/A | |
Alexander Chu | PVH Corp | N/A |
Management Performance
Return On Equity | -0.2 | ||||
Return On Asset | -0.14 |
OmniAb Inc Leadership Team
Elected by the shareholders, the OmniAb's board of directors comprises two types of representatives: OmniAb inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OmniAb. The board's role is to monitor OmniAb's management team and ensure that shareholders' interests are well served. OmniAb's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OmniAb's outside directors are responsible for providing unbiased perspectives on the board's policies.
Cia McCaffrey, Vice Talent | ||
Donna CPA, Senior Controller | ||
Bill Harriman, Senior Discovery | ||
Douglas Krafte, Senior Head | ||
Kurt Gustafson, Executive CFO | ||
MarieCecile DVM, Senior Genetics | ||
Charles JD, Chief Secretary | ||
Christel Iffland, Senior Technologies | ||
Matthew Foehr, CEO President |
OmniAb Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OmniAb a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.2 | ||||
Return On Asset | -0.14 | ||||
Operating Margin | (4.74) % | ||||
Number Of Shares Shorted | 20.6 K | ||||
Revenue | 34.16 M | ||||
EBITDA | (49.73 M) | ||||
Net Income | (50.62 M) | ||||
Total Debt | 25.56 M | ||||
Book Value Per Share | 2.43 X | ||||
Cash Flow From Operations | 2.35 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OmniAb Stock Analysis
When running OmniAb's price analysis, check to measure OmniAb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OmniAb is operating at the current time. Most of OmniAb's value examination focuses on studying past and present price action to predict the probability of OmniAb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OmniAb's price. Additionally, you may evaluate how the addition of OmniAb to your portfolios can decrease your overall portfolio volatility.